Difference between revisions of "Regimen classes"
Jump to navigation
Jump to search
Line 13: | Line 13: | ||
==Bevacizumab-containing regimen== | ==Bevacizumab-containing regimen== | ||
+ | =Dacarbazine-based regimen= | ||
=Endocrine-based regimen= | =Endocrine-based regimen= | ||
==Androgen receptor-directed therapy== | ==Androgen receptor-directed therapy== |
Revision as of 23:41, 21 August 2022
The purpose of this page is to define regimen classes that will be used in the HemOnc ontology; it is not for other purposes at this time.